/ /

LATEST

Dropless cataract surgery effective choice without compliance issuesDropless prophylaxis in patients scheduled to undergo cataract surgery seems to be more practical than and as efficacious as the standard of care for use in this patient population.
Here come the machines: Progress or replacing MDs?
Here come the machines: Progress or replacing MDs?Artificial intelligence and deep learning present an exciting opportunity and challenge to ophthalmologists and other physicians.
Managing treatment options for atopic keratoconjunctivitisEye or eyelid involvement in atopic dermatitis is relatively uncommon. However, the frequency and severity of corneal complications may accompany atopic keratoconjunctivitis and lead to vision loss. In all but the mildest cases of AKC, treatment typically consists of corticosteroids; calcineurin inhibitors may be added in more severe cases.
Presbyopic IOLs changing game for astigmatic patientsPresbyopia-correcting IOLs are changing the preoperative patient education discussion, making it easier for surgeons. However, the need for precision measurements and careful surgical technique may be more important than in the past.
The Retinator II: Judgment Day?
The Retinator II: Judgment Day?Hollywood loves trilogies, and though not all sequels are created equal, as a general rule, the second installment tends to be the best. The examples of this phenomenon are numerous (Godfather Part II, Back to the Future II, The Empire Strikes Back, etc.). However, the most-cultured Ophthalmology Times readers will no doubt point to Terminator II as the best example of all.
Risk review supports safety of corneal crosslinkingSevere complications are rare (< 1%) after corneal crosslinking for progressive keratoconus. Some are preventable, some are manageable, but some may lead to a need for corneal transplantation
Regenerative cell therapy, tissue engineering are future treatments
Regenerative cell therapy, tissue engineering are future treatmentsAdvances in endothelial and anterior lamellar keratoplasty have given it distinct advantages over penetrating keratoplasty, in corneal replacement. However, there are variations in outcomes from different centers. Moving forward, regenerative cell therapy and tissue engineering will be the future treatments of endothelial disease.
Anti-VEGF patients feel anxiety and depressionPatients receiving anti-vascular endothelial growth factor (VEGF) injections for neovascular (wet) age-related macular degeneration (AMD) often feel anxiety and depression about the treatment, researchers say.
ASCRS hits ‘La La Land’ for 2017 annual meeting
ASCRS hits ‘La La Land’ for 2017 annual meetingThe 2017 meeting of the American Society of Cataract and Refractive Surgery (ASCRS) will be held May 5 to 9 at the Los Angeles Convention Center, but at least one guest speaker will be sharing his “out-of-this-world” experiences.
ARVO 2017 awards in spotlightAs eye and vision researchers gather this month for the 2017 meeting of the Association for Research in Vision and Ophthalmology (ARVO), four members will be recognized for their contributions to ophthalmology and vision research with a 2017 ARVO Achievement Award and lecture.

Poll

View Results